← All trials
NCT04809376
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 26, 2021
- Primary completion
- Aug 17, 2022
- Completion date
- Jan 6, 2023
- First posted
- Mar 22, 2021
- Last posted
- Mar 22, 2021
- Enrollment
- 938
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Paradigm Biopharmaceuticals USA (INC)Lead sponsor
- Northwestern UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.